TipRanks
TipRanksTop Financial ExpertsInsidersMichael Metzger

Michael Metzger Insider Profile

4 Followers
Michael Metzger, CEO, Director at Syndax Pharmaceuticals, holds 484.84K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in Pyxis Oncology (Ticker: PYXS), holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA).
See the Hottest Stocks Based on Insider Trading >
tipranks
Michael Metzger

Michael Metzger
Syndax Pharmaceuticals (SNDX)
CEO, Director

Ranked #79,695 out of 109,287 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

-15.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$7M
100.00%
<0.01%
0.00%
A breakdown of Michael Metzger's holdings
See the Top Stocks by Insiders

Insider Roles

Syndax Pharmaceuticals
(SNDX)
CEO, Director
Response Genetics
(RGDXQ)
Director
Pyxis Oncology
(PYXS)
Director
Roles that Michael Metzger holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Syndax Pharmaceuticals
(SNDX)
Rating:Informative Sell
Date:Feb 10, 2026 - Today
Return:+39.40%
The most profitable trade made by Michael Metzger
See the Latest Stocks Traded by Insiders

Michael Metzger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SNDX
Syndax Pharmaceuticals
Jul 09, 2026
CEO, Director
Uninformative Buy
206.55K
$6.94M
PYXS
Pyxis Oncology
―
Director
―
―
TBRA
Tobira Therapeutics
―
―
―
$0.00
CTIC
CTI BioPharma
Jul 11, 2022
―
Uninformative Sell
130.99K
$0.00
RGDXQ
Response Genetics
Feb 06, 2012
Director
Informative Buy
1.50K
$14.00
List of latest transactions for each holding click on a transaction to see Michael Metzger's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Michael Metzger insider profile FAQ

What is the percentage of profitable transactions made by Michael Metzger?
The percentage of profitable transactions made by Michael Metzger is 60%.
    What is the average return per transaction made by Michael Metzger?
    The average return per transaction made by Michael Metzger is -15.00%.
      What stocks does Michael Metzger hold?
      Michael Metzger holds: SNDX, PYXS, TBRA, CTIC, RGDXQ stocks.
        What was Michael Metzger’s latest transaction?
        Michael Metzger latest transaction was an Uninformative Buy of $206.55K.
          What was Michael Metzger's most profitable transaction?
          Michael Metzger’s most profitable transaction was an Informative Sell of SNDX stock on February 10, 2026. The return on the trade was 39.40%.
            What is Michael Metzger's role in Syndax Pharmaceuticals?
            Michael Metzger's role in Syndax Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.